Tag: deferoxamine

Combination Study Halted

The National Heart, Lung and Blood Institute has halted its Cardiac Deferoxamine/L1 Study due to an inability to enroll a sufficient number of patients to provide statistically relevant results. The purpose of the study was to determine whether left ventricular function improves more rapidly with deferoxamine (DFO) and deferiprone (L1) combination therapy than with DFO […]

Read more

Secured By miniOrange